Yuval Mika
Technik-/Wissenschafts-/F&E-Leiter bei ORCHESTRA BIOMED HOLDINGS, INC.
Vermögen: 705 538 $ am 30.04.2024
Profil
Yuval Hay Mika is the founder of Impulse Dynamics (USA), Inc. He currently holds three positions as Chief Executive Officer at BackBeat Medical LLC, Chief Operating Officer at MetaCure (USA), Inc., and Chief Technology Officer & General Manager at Orchestra Biomed Holdings, Inc. Previously, he held the position of Chief Operating & Scientific Officer at Impulse Dynamics NV from 2005 to 2012.
He also worked as a Researcher at the University of California.
Dr. Mika received his undergraduate degree in 1988 and his doctorate in 1993 from Technion-Israel Institute of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.05.2024 | 158 905 ( 0,44% ) | 705 538 $ | 30.04.2024 |
Aktive Positionen von Yuval Mika
| Unternehmen | Position | Beginn |
|---|---|---|
| ORCHESTRA BIOMED HOLDINGS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 26.01.2023 |
BackBeat Medical LLC
 BackBeat Medical LLC Electronic Equipment/InstrumentsElectronic Technology BackBeat Medical, Inc. develops implantable cardiac stimulation devices. It offers devices for the treatment of hypertension. The firm provides apparatus to increase secretion of endogenous natriuretic hormones. The company was founded by Robert A. van Tassel in January 2011 and is headquartered in New Hope, PA. | Vorstandsvorsitzender | 01.01.2011 |
MetaCure (USA), Inc.
 MetaCure (USA), Inc. Pharmaceuticals: MajorHealth Technology MetaCure (USA), Inc. engages in the development and commercialization of invasive treatment for diabetes. The company was founded by Shlomo Ben-Haim in 2003 and is headquartered in Orangeburg, NY. | Geschäftsführer | 01.01.2005 |
Ehemalige bekannte Positionen von Yuval Mika
| Unternehmen | Position | Ende |
|---|---|---|
| University of California | Corporate Officer/Principal | - |
Impulse Dynamics (USA), Inc.
 Impulse Dynamics (USA), Inc. Medical SpecialtiesHealth Technology Impulse Dynamics Ltd. (US) develops implantable device for the treatment of chronic heart failure. The company is headquartered in Mount Laurel, NJ. | Vorstandsvorsitzender | - |
Impulse Dynamics NV
 Impulse Dynamics NV Electronic Equipment/InstrumentsElectronic Technology Impulse Dynamics NV develops electrical therapies for the treatment of chronic heart failure. Its product Optimizer III is designed for the treatment of patients with moderate and severe heart failure. The company was founded in 1996 and is headquartered in Willemstad, Netherlands Antilles. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Yuval Mika
| Technion-Israel Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ORCHESTRA BIOMED HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Impulse Dynamics NV
Impulse Dynamics NV Electronic Equipment/InstrumentsElectronic Technology Impulse Dynamics NV develops electrical therapies for the treatment of chronic heart failure. Its product Optimizer III is designed for the treatment of patients with moderate and severe heart failure. The company was founded in 1996 and is headquartered in Willemstad, Netherlands Antilles. | Electronic Technology |
Impulse Dynamics (USA), Inc.
Impulse Dynamics (USA), Inc. Medical SpecialtiesHealth Technology Impulse Dynamics Ltd. (US) develops implantable device for the treatment of chronic heart failure. The company is headquartered in Mount Laurel, NJ. | Health Technology |
BackBeat Medical LLC
BackBeat Medical LLC Electronic Equipment/InstrumentsElectronic Technology BackBeat Medical, Inc. develops implantable cardiac stimulation devices. It offers devices for the treatment of hypertension. The firm provides apparatus to increase secretion of endogenous natriuretic hormones. The company was founded by Robert A. van Tassel in January 2011 and is headquartered in New Hope, PA. | Electronic Technology |
MetaCure (USA), Inc.
MetaCure (USA), Inc. Pharmaceuticals: MajorHealth Technology MetaCure (USA), Inc. engages in the development and commercialization of invasive treatment for diabetes. The company was founded by Shlomo Ben-Haim in 2003 and is headquartered in Orangeburg, NY. | Health Technology |
